JPS6315280B2 - - Google Patents

Info

Publication number
JPS6315280B2
JPS6315280B2 JP52066576A JP6657677A JPS6315280B2 JP S6315280 B2 JPS6315280 B2 JP S6315280B2 JP 52066576 A JP52066576 A JP 52066576A JP 6657677 A JP6657677 A JP 6657677A JP S6315280 B2 JPS6315280 B2 JP S6315280B2
Authority
JP
Japan
Prior art keywords
peptide
cys
insulin
glucagon
resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52066576A
Other languages
English (en)
Japanese (ja)
Other versions
JPS52156885A (en
Inventor
Uokaa Beeru Juniaa Uirii
Edoaado Furederitsuku Ribiaa Jiin
Rosu Buraun Maabin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/785,533 external-priority patent/US4133782A/en
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of JPS52156885A publication Critical patent/JPS52156885A/ja
Publication of JPS6315280B2 publication Critical patent/JPS6315280B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP6657677A 1976-06-07 1977-06-06 Peptide compound Granted JPS52156885A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69328276A 1976-06-07 1976-06-07
US05/785,533 US4133782A (en) 1976-06-07 1977-04-07 Somatostatin analogs with dissociated biological activities

Publications (2)

Publication Number Publication Date
JPS52156885A JPS52156885A (en) 1977-12-27
JPS6315280B2 true JPS6315280B2 (cs) 1988-04-04

Family

ID=27105142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6657677A Granted JPS52156885A (en) 1976-06-07 1977-06-06 Peptide compound

Country Status (11)

Country Link
JP (1) JPS52156885A (cs)
AU (1) AU509631B2 (cs)
CA (1) CA1102313A (cs)
CH (1) CH640827A5 (cs)
DE (1) DE2725735A1 (cs)
DK (1) DK250977A (cs)
FR (1) FR2375190A1 (cs)
GB (1) GB1567341A (cs)
IL (1) IL52231A (cs)
NL (1) NL7706002A (cs)
SE (1) SE441452B (cs)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates

Also Published As

Publication number Publication date
FR2375190A1 (fr) 1978-07-21
SE7706567L (sv) 1977-12-08
NL7706002A (nl) 1977-12-09
IL52231A (en) 1980-05-30
DE2725735A1 (de) 1977-12-15
CA1102313A (en) 1981-06-02
AU2577577A (en) 1978-12-07
IL52231A0 (en) 1977-08-31
FR2375190B1 (cs) 1981-10-30
GB1567341A (en) 1980-05-14
CH640827A5 (en) 1984-01-31
AU509631B2 (en) 1980-05-22
DK250977A (da) 1977-12-08
JPS52156885A (en) 1977-12-27
SE441452B (sv) 1985-10-07

Similar Documents

Publication Publication Date Title
US4105603A (en) Peptides which effect release of hormones
FI83660B (fi) Foerfarande foer framstaellning bukspottskoertelns grf hos maenniskan.
US4316891A (en) Extended N-terminal somatostatin
US4211693A (en) Peptides with para-substituted phenylalanine
FI88402B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara grf-analoger
US4133782A (en) Somatostatin analogs with dissociated biological activities
US4000259A (en) Cyclic dodecapeptide analogs of somatostatin and intermediates
JPS60109600A (ja) 環状ヘキサペプチド，ソマトスタチン類似体
IE44532B1 (en) Somatostatin analogues
EP0017746B1 (en) Peptides having somatostatin activity, compositions comprising them and process for making the peptides
US4486415A (en) Cyclic hexapeptide somatostatin analogs
USRE30548E (en) Peptides which effect release of hormones
CA2274144C (en) Somatostatin antagonists
US4280953A (en) Glycosylated analogs of somatostatin
US4428942A (en) Analogs of somatostatin
US3933784A (en) Des-(ser13)-srif and intermediates
EP0021585B1 (en) Truncated somatostatin analogs and intermediates therefor, processes for their preparation, and pharmaceutical compositions containing the analogs
CA1247599A (en) Mammalian pgrf
EP0063885B1 (en) Analogs of extended n-terminal somatostatin
US4643989A (en) Inhibition of aldosterone secretion
JPS6315280B2 (cs)
US4816438A (en) Insulin-selective somatostatin analogs
Wan et al. Synthesis of the facteur thymique serique and an analog also related to thymopoietin
US3988308A (en) (Tyr3, Tyr14)-SRIF and intermediates
CA1333892C (en) Insulin-selective somatostatin analogs